Sarepta Therapeutics, Inc. (SRPT)

Sarepta Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	13,666	9,021	11,375	7,841	13,454	9,619
Market Cap Growth	0.20%	-20.70%	45.06%	-41.72%	39.87%	31.90%
Enterprise Value	13,655	8,723	11,003	6,864	12,588	9,224
PE Ratio	363.33	-16.83	-16.17	-18.72	-24.28	-13.45
PS Ratio	9.74	7.26	12.19	11.17	24.91	25.26
PB Ratio	14.22	10.50	29.55	8.45	17.66	11.76
P/FCF Ratio	-19.20	-15.63	-31.94	-16.28	532.53	-18.64
P/OCF Ratio	-22.77	-18.01	-34.96	-17.69	125.19	-21.07
EV/Sales Ratio	9.73	7.02	11.79	9.78	23.31	24.22
EV/EBITDA Ratio	149.85	-18.91	-17.32	-18.57	-24.52	-13.50
EV/EBIT Ratio	400.91	-16.77	-15.95	-16.38	-22.76	-12.92
EV/FCF Ratio	-19.19	-15.12	-30.89	-14.25	498.27	-17.87
Debt / Equity Ratio	1.44	1.60	4.20	1.23	1.41	0.89
Debt / EBITDA Ratio	15.14	-2.99	-2.55	-3.08	-2.09	-1.07
Debt / FCF Ratio	-2.18	-2.39	-4.54	-2.36	42.47	-1.41
Quick Ratio	2.91	3.18	3.56	5.01	4.90	4.59
Current Ratio	4.05	3.95	4.13	5.75	5.97	5.55
Asset Turnover	0.44	0.40	0.30	0.25	0.19	0.21
Return on Equity (ROE)	2.00%	-69.70%	-117.30%	-69.30%	-57.70%	-67.10%
Return on Assets (ROA)	0.50%	-17.10%	-22.80%	-14.80%	-19.10%	-39.50%
Return on Capital (ROIC)	-2.01%	-11.97%	-26.78%	-22.25%	-30.75%	-45.58%
Earnings Yield	0.12%	-5.94%	-6.18%	-5.34%	-4.12%	-7.43%
FCF Yield	-4.63%	-6.40%	-3.13%	-6.14%	0.19%	-5.37%
Buyback Yield / Dilution	-12.39%	-5.53%	-7.75%	-4.24%	-5.90%	-11.12%
Total Shareholder Return	-12.39%	-5.53%	-7.75%	-4.24%	-5.90%	-11.12%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).